WO1997021356A1 - Mineral enriched beverages - Google Patents

Mineral enriched beverages Download PDF

Info

Publication number
WO1997021356A1
WO1997021356A1 PCT/GB1996/003038 GB9603038W WO9721356A1 WO 1997021356 A1 WO1997021356 A1 WO 1997021356A1 GB 9603038 W GB9603038 W GB 9603038W WO 9721356 A1 WO9721356 A1 WO 9721356A1
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
magnesium
beverage
acid
enriched beverage
Prior art date
Application number
PCT/GB1996/003038
Other languages
French (fr)
Inventor
Brian Anthony Whittle
Original Assignee
Brian Whittle Associates Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brian Whittle Associates Limited filed Critical Brian Whittle Associates Limited
Publication of WO1997021356A1 publication Critical patent/WO1997021356A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements

Definitions

  • the present invention relates to a
  • beverage comprising calcium and/or magnesium and a
  • calcium and magnesium are the principal mineral elements of the skeleton and other calcified structures such as teeth; both are needed for healthy development and maintenance of bones and teeth.
  • the mineral elements in these structures are subject to turnover and are needed on a continuing basis for rermneralisation of teeth and bone.
  • Health problems can arise when the net loss of calcium and magnesium are greater than the rate of remineralisation.
  • Hormonal factors control the utilisation of calcium in the body but a minimum intake of calcium from diet is necessary.
  • the principal types of treatment are:-
  • HRT Hormone replacement therapy
  • hormones and vitamins which modulate calcium turnover and conservation such as calciferol, diphosphonates , parathyroid hormone, and calcitonin.
  • Oral calcium tablets and mixtures may be used therapeutically, alone or in combination with other therapies.
  • RDA daily allowance
  • Formulations In generating formulations which meet regulatory requirements of a range of countries, proportions are 1250mg calcium and 250mg magnesium/litre have been used. Formulations may be varied pro rata to provide solutions with more or less minerals content .
  • the usual dietary sources of calcium and magnesium are milk and dairy products.
  • a mineralised drink with a defined content of calcium and magnesium, and which is also socially acceptable is an attractive way of supplementing the intake of calcium and magnesium for subjects at risk.
  • Mains waters contain variable contents of calcium . Those containing 50-100ppm are classified as “Hard”, and the hardest waters contain 150ppm . The hardness is caused by dissolved calcium and magnesium salts "Permanent hardness is due to silicates and sulphates which remain in solution after boiling and “temporary hardness” is removed by boiling which converts the soluble bicarbonates to insoluble carbonates.
  • Inorganic salts which are candidates as soluble calcium and magnesium sources are:
  • Sulphate - CaSO 4 has a pleasant taste but has low solubility Mg SO 4 is soluble but has an unpleasant brackish taste.
  • Nitrate/nitrite - levels of more than 50ppm in drinking water are banned in most countries.
  • Monophosphate - can be used at certain levels of pH but gives cloudy solutions and may react with other soluble salts to give the insoluble di- and tri-phosphates.
  • Japanese Application No. 77/69999 15 June 1977 describes the preparation of calcium-enriched soft drinks by adding organic salts of calcium produced from sea shells.
  • 3 parts of a 3 : 1 mixture of fructose and invert sugar, 4 parts of a 3 : 1 mixture of orange and lemon juices, and 90 parts water were mixed and conventionally bottled.
  • the calcium used to prepare the calcium salts was made by calcining sea shells at 1 ,000 - 1 ,200oC for one hour, treated to remove heavy metals and re-calcined at the same temperature to produce calcium oxide which was dissolved in water and treated with organic acid to yield a calcium salt .
  • European Patent No 0507157 granted to Deutsch Granini GmbH refers to the formulation of fruit juices containing calcium lactate, magnesium gluconate and iron (II) gluconate.
  • International Patent Application No PCT/US93/09925 by Procter and Gamble describes a sweetener supplement composition and method for production thereof, providing biologically available calcium compounds comprising:
  • an edible acid component comprising a defined mixture of citric acid and malic acid
  • an acidic anion component selected from the group consisting of chloride anion, nitrate anion, sulphate ion and mixtures thereof
  • the beverage concentrate has a pH of less than or equal to about 4.5, preferably less than or equal to about 3.5 and is stable at temperatures of greater than about 32oC for at least about 4 hours , preferably at least about 3 days .
  • US patent No 5422128 describes the composition and preparation of storage-stable beverage concentrates for preparing beverages and food compositions containing calcium and a mixture of citric acid and malic acid with a defined weight ratio of citric to malic acid.
  • an acidic anion component selected from a group consisting of chloride, nitrate, sulphate and mixtures thereof.
  • US Patent No. 5401524 (The Procter and Gamble Company) relates to storage-stable beverage premix concentrates for preparing syrups, beverages and food compositions which are supplemented with calcium and methods for preparing these concentrates.
  • the specifications relate specifically to calcium, and the edible acid component is a mixture of citric acid and malic acid within specified ratios . Additionally, further solubilisation is achieved by addition of 0% - 4% of an inorganic anion.
  • the beverage concentrates are stable at temperatures above 32oC for at least four hours .
  • US Patent No . 5389387 (The Procter and Gamble Company) describes the preparation of storage-stable beverage concentrates for preparing beverages and food compositions with a supplement of calcium, and a method of preparation of the concentrate.
  • the beverage concentrates have a greater than 5-fold concentration.
  • the solutions contain a solubilised calcium component and an acid component comprising a mixture of citric and malic acid.
  • US Patent No. 5444837 (The Procter and Gamble Company) relates to sweetener supplements which provide a bioavailable source of calcium and are stable (no calcium salt precipitation for at least 4 hours at temperatures of at least 29oC).
  • the mineral content is calcium and the acid component is a mixture of citric acid and malic acid at defined ratios.
  • the formulations also contain sugars.
  • the sugar alcohol is selected from glycerol , disaccharide alcohols, tetritols, pentitols ,
  • the sugar alcohol is present in an amount of 0 . 1 to 40% by weight of the beverage, more
  • the calcium and/or magnesium salt is present in an amount of 0 .1 to 10% by weight of the
  • beverage more preferably 0 .3 to 5% by weight .
  • the calcium salt may be selected from one or more of a carbonate , hydroxide , sulphate , nitrate ,
  • the magnesium salt may be selected from one or more of a carbonate , oxide , hydroxide , acetate , glycerophosphate , gluconate or lactate .
  • the beverage may comprise a nutritionally acceptable acid component selected from a mono, di , or trivalent organic acid of an aliphatic or hydroxy aliphatic acid; phosphoric acid;
  • the mono, di or trivalent acid is selected from one or more of citric , fumaric , malic , lactic , adipic and tartaric acid .
  • the acid comprises from 0 . 1 to 5% by weight of the beverage , more preferably from 0 . 1 to 2% by weight .
  • the beverage may additionally comprise one or more of a f lavouring, a colouring and a preservative .
  • the beverage has a pH of from about 2 . 5 to about 6 , more preferably from about 3 .2 to about 4 . 1 .
  • the preferred composition comprises calcium and magnesium, which are present in amounts of above 500 ppm calcium and above 75 ppm magnesium, more preferably about 1000 ppm of calcium and about 125 ppm magnesium .
  • a method for increasing the solubility of a calcium and/or magnesium salt in solution comprising adding a sugar alcohol to a
  • Preformed magnesium salts which would be expected to be suitable as soluble sources are not practicable because of their bitter taste.
  • a particular example is magnesium lactate which has an unacceptable, very bitter taste and also imparts a distinct colour to the solution.
  • the addition of a polyol to solutions of calcium and/or magnesium compounds helps to mask any after taste. They have a different taste from those formed by the addition of pre-formed calcium and magnesium salts of the same acids.
  • a feature of the invention is the provision of a pre-mix in the form of a liquid or sol id which when added to potabl e water produces a sol uti on which can be used as a mineral supplement.
  • a supplement can be in the form of a "still" mineral-type water, or may be carbonated by addition of 1 -4 volumes of CO 2 .
  • bolyols can increase the solubility of calcium and/or magnesium compounds and produce stable solution of malate or citrate, or malate/citrate de do not precipitate i nsol ubl e crystals on standing).
  • Nutritionally acceptable polyols with at least three hydroxyl groups are effective, diglycol is unacceptable as a food additive.
  • polyols are polyhydric alcohols as defined in Kirk Othmer (Encycloppedia of Chemical Technology, Third Edition, page 754).
  • compositions containing a calcium and/or a magnesium compound a polyol containing preferably at least three hydroxyl groups and a single di- or tri-basic organic anion or a combination thereof have practical utility in that they can be used to produce mineral supplements containing calcium and magnesium.
  • the inclusion of both calcium and magnesium is preferred since both of these minerals are required for healthy bones and teeth.
  • the use of polyols rather than sugars has other benefi ts, for example inhibition of plaque accumulation, suppression of cariogenic bacteria and taste masking properties.
  • Figures 1 and 2 show the effect of increasing concentrations of polyol on the Index of Precipitation.
  • Xylitol and lactitol have a greater solubilising effect than glycerol, sorbitol and maltitol.
  • Figure 3 shows the stabilising effect of addition of glycerol to a solution containing Calcium malate.
  • the standard solution described is a calcium carbonate slurry neutralised with malic acid to pH 3.8, with no glycerol added.
  • the calcium and magnesium carbonate dissolve in the solution with evolution of carbon dioxide.
  • the solution was cooled to 4oC and carbonated with 2.5 volumes of carbon dioxide.
  • the resulting solution contains 1000ppm of calcium and 125ppm of magnesium with a pH of 3.8.
  • polyol or combination of polyols at the following ranges :
  • the calcium carbonate and magnesium carbonate dissolve in the solution giving rise to carbon dioxide release, the other calcium salts dissolve in the solution on stirring. During this time the polyol content is added and the solution allowed to clear. The resulting solution is allowed to cool to 4oC and is carbonated with 2 5 - 3.0 volumes of carbon dioxide. These solutions contain approximately 1000ppm and 125ppm of magnesium with a pH range of 3.2 - 4.1.

Abstract

The use of a sugar alcohol to improve the solubility of a calcium and/or magnesium salt in the manufacture of a calcium or magnesium enriched beverage. A calcium and/or magnesium enriched beverage comprising at least one calcium and/or at least one magnesium salt and a sugar alcohol. A method for increasing the solubility of a calcium and/or magnesium salt in solution comprising adding a sugar alcohol to a solution of a calcium and/or a magnesium salt.

Description

MINERAL ENRICHED BEVERAGES
The present invention relates to a
nutritional composition, and more particularly to a
beverage comprising calcium and/or magnesium and a
method of maintaining the calcium and/or magnesium in
solution during storage .
It is known that calcium and magnesium are the principal mineral elements of the skeleton and other calcified structures such as teeth; both are needed for healthy development and maintenance of bones and teeth. The mineral elements in these structures are subject to turnover and are needed on a continuing basis for rermneralisation of teeth and bone. Health problems (including osteoporosis and dental canes) can arise when the net loss of calcium and magnesium are greater than the rate of remineralisation. Hormonal factors control the utilisation of calcium in the body but a minimum intake of calcium from diet is necessary. The principal types of treatment are:-
Hormone replacement therapy (HRT). This is effective in preventing bone less which is most marked in women and is at the rate of about 1% per day from ace 35 onwards. The loss of bone (osteoporosis) is responsible far fractures and collapse of vertebrae, with resulting loss of stature and morbidity.
Other hormones and vitamins which modulate calcium turnover and conservation such as calciferol, diphosphonates , parathyroid hormone, and calcitonin.
Oral calcium tablets and mixtures may be used therapeutically, alone or in combination with other therapies.
None of the treatments listed above reverse the reduction of bone density which results from the loss of minerals but slow down the rate of loss. Same of the "drugs" far which therapeutic claims are made are not without risk. The first two above work better if there is adequate supplementation of calcium in the diet. Recent clinical studies snow that doses of more than 1 ,000mg calcium per day taken as a dietary supplement are as effective as some hormonal treatments in reducing the rate of bone loss. The bones and teeth are the principal storage sites of minerals in the body and in view of daily excretion in urine and faeces of minerals regular replenishment is required .
The recommended daily allowance (RDA) depends on age and physiological condition The need for additional calcium and magnesium is greatest during period of rapid growth, pregnancy and lactation and in the elderly where absorption of minerals is less than optimal There are differences in RDA in various countries eg:-
UK - 500mg Calcium,
USA - 800mg Calcium, 350 mg Magnesium
Canada - 1 100mg Calcium, 250mg Magnesium
In generating formulations which meet regulatory requirements of a range of countries, proportions are 1250mg calcium and 250mg magnesium/litre have been used. Formulations may be varied pro rata to provide solutions with more or less minerals content .
Existing mineral supplements which are perceived as 'drugs' are not "patient friendly", there is therefore a need for a product wh ich can be taken as a nutri ti onal product .
The usual dietary sources of calcium and magnesium are milk and dairy products.
These also contain carbohydrate calories (lactose), and half- or full-cream milk contains 2-4% or more of butter fat, and the associated cholesterol Some consumers dislike milk or are allergic to it. A mineralised drink with a defined content of calcium and magnesium, and which is also socially acceptable is an attractive way of supplementing the intake of calcium and magnesium for subjects at risk.
Mains waters contain variable contents of calcium . Those containing 50-100ppm are classified as "Hard", and the hardest waters contain 150ppm . The hardness is caused by dissolved calcium and magnesium salts "Permanent hardness is due to silicates and sulphates which remain in solution after boiling and "temporary hardness" is removed by boiling which converts the soluble bicarbonates to insoluble carbonates.
When ground water saturated with carbon dioxide drains through limestone rocks the carbonic acid so formed reacts with calcium and magnesium carbonates to form bicarbonates which are responsible for temporary hardness. Sparkling mineral waters are carbonated either naturally or artificially, and the dissolved carbon dioxide which is in equilibrium with bicarbonate ion causes the calcium and magnesium salts to remain in solution. Approximately 250ppm represents the maximum amount of calcium and magnesium which can be held in solution in natural mineral waters. On exposure to the atmosphere these solutions tend to lose carbon dioxide and may become cloudy.
It was has been found that the amount of calcium and magnesium can be increased substantially above this level and to levels which allow a significant proportion of the RDA of these minerals to be taken as a drink in a convenient volume by adding one or more calcium and magnesium salts.
Inorganic salts which are candidates as soluble calcium and magnesium sources are:
Chloride - unsuitable at the dose required because of its acrid taste at high concentration. Hypertension ?
Sulphate - CaSO4 has a pleasant taste but has low solubility Mg SO4 is soluble but has an unpleasant brackish taste.
Nitrate/nitrite - levels of more than 50ppm in drinking water are banned in most countries. Monophosphate - can be used at certain levels of pH but gives cloudy solutions and may react with other soluble salts to give the insoluble di- and tri-phosphates.
Organic salts of calcium and magnesium are attractive sources of these minerals in drinks. However it was found that at certain values of pH, within the range normally found in beverages, solutions which were clear initially deposited crystals on storage. The search for suitable sources of calcium which can be used to make still or carbonated drinks has been the subject of several studies. The prior art includes:
Japanese Application No. 77/69999 15 June 1977 describes the preparation of calcium-enriched soft drinks by adding organic salts of calcium produced from sea shells. 3 parts of a 1 : 1 : 1 mixture of calcium citrate, calcium malate and calcium lactate. 3 parts of a 3 : 1 mixture of fructose and invert sugar, 4 parts of a 3 : 1 mixture of orange and lemon juices, and 90 parts water were mixed and conventionally bottled. The calcium used to prepare the calcium salts was made by calcining sea shells at 1 ,000 - 1 ,200ºC for one hour, treated to remove heavy metals and re-calcined at the same temperature to produce calcium oxide which was dissolved in water and treated with organic acid to yield a calcium salt .
European Patent Application No 80304177.1 , by Monsanto Company, filed 21 November 1990, describes the preparation of amorphous calcium carbonate containing water of crystallisation and which is thereby rendered more readily soluble than crystalline anhydrous calcium carbonate. The use of other, naturally occurring forms of calcium carbonate for preparation of nutritional supplements is well known.
European Patent No 0507157 granted to Deutsch Granini GmbH (priority date 5 April 1991 ) refers to the formulation of fruit juices containing calcium lactate, magnesium gluconate and iron (II) gluconate. International Patent Application No PCT/US93/09925 by Procter and Gamble (priority date 18 October 1992) describes a sweetener supplement composition and method for production thereof, providing biologically available calcium compounds comprising:
(a) solubilised calcium
(b) a defined mixture of citric and malic acid or corresponding acid salts which will react with (a)
(c) a sugar (preferably fructose)
(d) water
International Patent Application No PCT/US93/09926 - Procter and Gamble (priority date 18 October 1993) further defines the ratio of citric and malic acid salts of calcium to provide a stable composition containing sugars.
International Patent Application No PCT/US/9309927 - Procter and Gamble claiming priority from 18 October 1993, refers to storage-stable beverage premix concentrates for preparing syrups beverages and food compositions which are nutritionally supplemented with significant levels of calcium, but not magnesium, and to methods for preparing these concentrates Further, concentrates have a greater than 10 fold concentration and comprise:
(a) solubilized calcium
(b) an edible acid component comprising a defined mixture of citric acid and malic acid (c) an acidic anion component selected from the group consisting of chloride anion, nitrate anion, sulphate ion and mixtures thereof
(d) an effective amount of a flavour component, and
(e) from about 5% to about 70% sugar, on a dry weight basis.
The beverage concentrate has a pH of less than or equal to about 4.5, preferably less than or equal to about 3.5 and is stable at temperatures of greater than about 32ºC for at least about 4 hours , preferably at least about 3 days .
US patent No 5422128 describes the composition and preparation of storage-stable beverage concentrates for preparing beverages and food compositions containing calcium and a mixture of citric acid and malic acid with a defined weight ratio of citric to malic acid. There is also a claim to an acidic anion component selected from a group consisting of chloride, nitrate, sulphate and mixtures thereof.
US Patent No. 5401524 (The Procter and Gamble Company) relates to storage-stable beverage premix concentrates for preparing syrups, beverages and food compositions which are supplemented with calcium and methods for preparing these concentrates. The specifications relate specifically to calcium, and the edible acid component is a mixture of citric acid and malic acid within specified ratios . Additionally, further solubilisation is achieved by addition of 0% - 4% of an inorganic anion. The beverage concentrates are stable at temperatures above 32ºC for at least four hours .
US Patent No . 5389387 (The Procter and Gamble Company) describes the preparation of storage-stable beverage concentrates for preparing beverages and food compositions with a supplement of calcium, and a method of preparation of the concentrate. The beverage concentrates have a greater than 5-fold concentration. The solutions contain a solubilised calcium component and an acid component comprising a mixture of citric and malic acid.
US Patent No. 5444837 (The Procter and Gamble Company) relates to sweetener supplements which provide a bioavailable source of calcium and are stable (no calcium salt precipitation for at least 4 hours at temperatures of at least 29ºC). The mineral content is calcium and the acid component is a mixture of citric acid and malic acid at defined ratios. The formulations also contain sugars.
Each of the patents cited as prior art, rely on careful definition of the amounts of organic acids particularly citric and malic acid which must both be present to give the solubility effect, none of the patents refer to the importance of magnesium which is also known to be a structural element in bone,
It has been found by experiment that the use of pre-formed magnesium salts, particularly the lactate and citrate, gives rise to products which have an intense bitter taste. The teaching of these patents cannot be relied upon to arrive at useful compositions as dietary supplements of magnesium and calcium if pre-formed salts are used. Surprisingly it has been found that a simple and cost-effective way of producing a stable solution of calcium and/or magnesium which is not only free of the bitter taste associated with pre-formed magnesium salts but has an acceptable taste can be achieved by adding calcium and/or magnesium as carbonates, oxides or hydroxides and solubiltsing in the presence of a polyol. Calcium can be added in the form of a nutritionally acceptable aliphatic or hydroxy aliphatic acids or acid salt. Calcium can also be added in the form of glycerophosphate and acid phosphate.
According to a first aspect of the present invention there is provided the use of a sugar alcohol
to improve the solubility of a calcium and/or magnesium salt in the manufacture of a calcium or magnesiun
enriched beverage .
Preferably the sugar alcohol is selected from glycerol , disaccharide alcohols, tetritols, pentitols ,
hexitols and heptitols .
According to a second aspect of the present invention there is provided a calcium and/or magnesium
enriched beverage comprising at least one calcium
and/or at least one magnesium salt and a sugar alcohol .
Preferably, the sugar alcohol is present in an amount of 0 . 1 to 40% by weight of the beverage, more
preferably 0 .5 to 20%, and more preferably still about
10% .
Preferably, the calcium and/or magnesium salt is present in an amount of 0 .1 to 10% by weight of the
beverage , more preferably 0 .3 to 5% by weight .
The calcium salt may be selected from one or more of a carbonate , hydroxide , sulphate , nitrate ,
oxide , acetate, glycerophosphate, gluconate , lactate or
monophosphate .
The magnesium salt may be selected from one or more of a carbonate , oxide , hydroxide , acetate , glycerophosphate , gluconate or lactate .
Additionally, the beverage may comprise a nutritionally acceptable acid component selected from a mono, di , or trivalent organic acid of an aliphatic or hydroxy aliphatic acid; phosphoric acid;
glycerophosphoric acid and gluconic acid.
Preferably, the mono, di or trivalent acid is selected from one or more of citric , fumaric , malic , lactic , adipic and tartaric acid .
Preferably, the acid comprises from 0 . 1 to 5% by weight of the beverage , more preferably from 0 . 1 to 2% by weight .
The beverage may additionally comprise one or more of a f lavouring, a colouring and a preservative .
Preferably, the beverage has a pH of from about 2 . 5 to about 6 , more preferably from about 3 .2 to about 4 . 1 .
The preferred composition comprises calcium and magnesium, which are present in amounts of above 500 ppm calcium and above 75 ppm magnesium, more preferably about 1000 ppm of calcium and about 125 ppm magnesium .
According to a third aspect of the present invention there is provided a method for increasing the solubility of a calcium and/or magnesium salt in solution comprising adding a sugar alcohol to a
solution of a calcium and/or magnesium salt . Whereas previous attempts at mineral supplementation have concentrated on the provision of additional calcium, it is equally important that there is a balance of magnesium and calcium in such supplements. One of the effects of increasing the amount of calcium in diet is to produce a constipating effect; magnesium has the opposite effect. It is therefore beneficial to have a mixture of magnesium and calcium sources in such a supplement.
Preformed magnesium salts which would be expected to be suitable as soluble sources are not practicable because of their bitter taste. A particular example is magnesium lactate which has an unacceptable, very bitter taste and also imparts a distinct colour to the solution. The addition of a polyol to solutions of calcium and/or magnesium compounds helps to mask any after taste. They have a different taste from those formed by the addition of pre-formed calcium and magnesium salts of the same acids.
A feature of the invention is the provision of a pre-mix in the form of a liquid or sol id which when added to potabl e water produces a sol uti on which can be used as a mineral supplement. Such a supplement can be in the form of a "still" mineral-type water, or may be carbonated by addition of 1 -4 volumes of CO2.
Kirk Othmer (Encyclopedia of Chemical Technology) refers to the solubilisation of calcium salts by sugar alcohols at high values of pH, but does not indicate differences in the activity of individual sugar alcohols, particularly at low pH values. These have been discovered by experiment. The choice of sugar alcohol will also depend on regulatory considerations in each territory.
It is suggested in the prior art (and has been confirmed by experiment) that solutions containing the calcium salt of one of malic citric or tartaric acid are prone to develop crystals which do not subsequently re-dissolve on standing. In the prior art this problem has been addressed by forming soluble and stable calcium salt solutions of calcium malate and citrate. Both organic anions are required to produce a solution stable enough to be useful in practice.
It has been found by experiment that bolyols can increase the solubility of calcium and/or magnesium compounds and produce stable solution of malate or citrate, or malate/citrate de do not precipitate i nsol ubl e crystals on standing). Nutritionally acceptable polyols with at least three hydroxyl groups are effective, diglycol is unacceptable as a food additive. In this specification polyols are polyhydric alcohols as defined in Kirk Othmer (Encycloppedia of Chemical Technology, Third Edition, page 754).
Compositions containing a calcium and/or a magnesium compound a polyol containing preferably at least three hydroxyl groups and a single di- or tri-basic organic anion or a combination thereof have practical utility in that they can be used to produce mineral supplements containing calcium and magnesium. The inclusion of both calcium and magnesium is preferred since both of these minerals are required for healthy bones and teeth. The use of polyols rather than sugars has other benefi ts, for example inhibition of plaque accumulation, suppression of cariogenic bacteria and taste masking properties.
In experiments where solutions of calcium malate were examined as potential calcium sources, there was precipitation of calcium malate after the first freeze-thaw cycle which was not subsequently dissolvable. When 5-10% of concentrated apple juice was added to the solution to provide a flavouring component it was found that precipitation of calcium malate was prevented. Subsequent analysis showed that concentrated apple juice contains sugars and also polyols.
Examination of products in the market have shown that some solutions containing soluble calcium salts may precipitate on storage. A method of defining the tendency of calcium-containing solutions to precipitate irreversibly has been devised by subjecting the solution to repeated freeze/thaw cycles. The "Index of Precipitation" described in Figures 1 and 2 refer to the number of freeze/thaw cycles at which precipitation may occur. For practical purposes, solutions which have an Index of Precipitation of 3, ie are stable for at least three cycles, do not precipitate on storage at refrigerator or room temperature during normal shelf life of beverages (3 - 9 months).
Figures 1 and 2 show the effect of increasing concentrations of polyol on the Index of Precipitation. Xylitol and lactitol have a greater solubilising effect than glycerol, sorbitol and maltitol.
Figure 3 shows the stabilising effect of addition of glycerol to a solution containing Calcium malate. The standard solution described is a calcium carbonate slurry neutralised with malic acid to pH 3.8, with no glycerol added.
The solution tested in figures 1 to 3 were solutions A to E, which were prepared as per example 1
below:
Example 1 :
Solutions were prepared from
Figure imgf000015_0001
The calcium and magnesium carbonate dissolve in the solution with evolution of carbon dioxide. The solution was cooled to 4ºC and carbonated with 2.5 volumes of carbon dioxide. The resulting solution contains 1000ppm of calcium and 125ppm of magnesium with a pH of 3.8.
The solution was frozen at -18ºC and allowed to thaw (this process causes loss of some dissolved carbon dioxide but does not interfere with the purpose of the experiment). The solution was examined for deposits of crystals which did not redissolve at room temperature (25ºC). The freeze/thawing cycle was repeated up to ten times. The number of freeze/thaw cycles during which solutions re-dissolve at room temperature (Index of Precipitation) has been found to correlate with stability of solutions at storage temperatures of 4-30ºC for several months. Other compos itions illustrative of the invention are shown in example 2 below :
Example 2:
Solutions were prepared from:
Figure imgf000016_0001
Added to the above variations is a polyol or combination of polyols at the following ranges :
Figure imgf000016_0002
The calcium carbonate and magnesium carbonate dissolve in the solution giving rise to carbon dioxide release, the other calcium salts dissolve in the solution on stirring. During this time the polyol content is added and the solution allowed to clear. The resulting solution is allowed to cool to 4ºC and is carbonated with 2 5 - 3.0 volumes of carbon dioxide. These solutions contain approximately 1000ppm and 125ppm of magnesium with a pH range of 3.2 - 4.1.

Claims

1. The use of a sugar alcohol to improve the solubility of a calcium and/or magnesium salt in the manufacture of a calcium or magnesium enriched
beverage.
2. A use as claimed in claim 1 wherein the sugar alcohol is selected from the group consisting of glycerol, disaccharide alcohols, tetritols, pentitols, hexitols and heptitols.
3. A use as claimed in claim 2 wherein the pentitol is xylitol.
4. A use as claimed in claim 2 wherein the hexitol is sorbitol.
5. A use as claimed in claim 2 wherein the disaccharide alcohol is maltitol or lactitol.
6. A use as claimed in any of claims 1 to 5 wherein the beverage comprises at least one calcium and at least one magnesium salt.
7. A calcium and/or magnesium enriched beverage comprising at least one calcium and/or at least one magnesium salt and a sugar alcohol.
8. A calcium and/or magnesium enriched beverage as claimed in claim 7 wherein the sugar alcohol is selected from the group consisting of glycerol, disaccharide alcohols, tetritols, pentitols, hexitols and heptitols.
9. A calcium and/or magnesium enriched beverage wherein the sugar alchol comprises from 0.1 to 40% by weight of the beverage.
10. A calcium and/or magnesium enriched beverage as claimed in claim 9 wherein the sugar alcohol comprises from 0.5 to 20% by weight as the beverage.
11. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 10 wherein the at least one calcium and/or at least one magnesium salt comprises from 0.1 to 10% by weight of the beverage.
12. A calcium and/or magnesium enriched beverage as claimed in claim 11 wherein the at least one calcium and/or at least one magnesium salt
comprises from 0.3 to 5% by weight of the beverage.
13. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 12 wherein the at least one calcium salt is selected from one or more of a carbonate, hydroxide, chloride, sulphate, nitrate, oxide, acetate, glycerophosphate, gluconate, lactate or monophosphate.
14. A calcium and/or magnesium enriched beverage as claimed in claims 7 to 13 wherein the magnesium salt is selected from one or more of a carbonate, oxide, hydroxide acetate, glycerophosphate, gluconate or lactate.
15. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 14 which further comprises a nutritionally acceptable acid component selected from a mono, di, or trivalent organic acid of an aliphatic or hydroxy aliphatic acid; phosphoric acid; glycerophosphoric acid and gluconic acid.
16. A calcium and/or magnesium enriched beverage as claimed in claim 15 wherein the mono, di or trivalent organic acid is selected from one or more of citric, fumaric, malic, lactic, adipic and tartaric acid.
17. A calcium and/or magnesium enriched beverage as claimed in any of claims 15 or 16 in which the acid comprises from 0.1 to 5% by weight of the beverage.
18. A calcium and/or magnesium enriched beverage as claimed in any of claims 15 to 17 in which the acid comprises from 0.1 to 2% by weight of the beverage.
19. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 18 which further comprises one or more of a flavouring, a colouring and a preservative.
20. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 19 which is an effervescent beverage.
21. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 20 which has a pH of 2.5 to 6.0.
22. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 21 which comprises both calcium and magnesium.
23. A calcium and/or magnesium enriched beverage as claimed in any of claims 7 to 22 which comprises above 500 ppm calcium and above 75 ppm magnesium.
24. A method for increasing the solubility of a calcium and/or magnesium salt in solution comprising adding a sugar alcohol to a solution of a calcium and/or a magnesium salt.
PCT/GB1996/003038 1995-12-11 1996-12-11 Mineral enriched beverages WO1997021356A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9525290.4A GB9525290D0 (en) 1995-12-11 1995-12-11 Nutritional compositions
GB9525290.4 1995-12-11

Publications (1)

Publication Number Publication Date
WO1997021356A1 true WO1997021356A1 (en) 1997-06-19

Family

ID=10785242

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/003038 WO1997021356A1 (en) 1995-12-11 1996-12-11 Mineral enriched beverages

Country Status (2)

Country Link
GB (1) GB9525290D0 (en)
WO (1) WO1997021356A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319490B1 (en) * 1996-02-20 2001-11-20 Smithkline Beecham Plc Liquid oral compositions comprising a calcium compound and an acidulant
US6383473B1 (en) 1997-08-19 2002-05-07 Smithkline Beecham P.L.C. Solid composition for reducing tooth erosion
WO2002052959A2 (en) * 2001-01-04 2002-07-11 The Procter & Gamble Company Beverage compositions comprising palatable calcium and magnesium sources
US6569477B2 (en) 1999-03-09 2003-05-27 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium and methods of making
US20140161955A1 (en) * 2011-12-13 2014-06-12 Manpreet S. Wadhwa Liquid Dietary Supplement Formulation Compositions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (en) * 1980-07-31 1982-05-12 Uwe Olthoff METHOD FOR PRODUCING STABILIZED CALCIUM-CONTAINING INJECTION SOLUTIONS
JPS5931710A (en) * 1982-08-17 1984-02-20 Masaki Takahara Drinking solution for supplying calcium
EP0185196A2 (en) * 1984-12-13 1986-06-25 Societe Des Produits Nestle S.A. Carbonation agent
EP0312249A1 (en) * 1987-10-14 1989-04-19 Takeda Chemical Industries, Ltd. Aqueous pharmaceutical preparation for oral administration
EP0343703A2 (en) * 1988-05-26 1989-11-29 The Procter & Gamble Company Mineral supplements with sugar alcohols
JPH0567A (en) * 1991-06-20 1993-01-08 Towa Kasei Kogyo Kk Calcium-and dietary-fiber containing food and drink and production thereof
JPH0769902A (en) * 1993-02-25 1995-03-14 Meiji Seika Kaisha Ltd Magnesium replenishing material

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (en) * 1980-07-31 1982-05-12 Uwe Olthoff METHOD FOR PRODUCING STABILIZED CALCIUM-CONTAINING INJECTION SOLUTIONS
JPS5931710A (en) * 1982-08-17 1984-02-20 Masaki Takahara Drinking solution for supplying calcium
EP0185196A2 (en) * 1984-12-13 1986-06-25 Societe Des Produits Nestle S.A. Carbonation agent
EP0312249A1 (en) * 1987-10-14 1989-04-19 Takeda Chemical Industries, Ltd. Aqueous pharmaceutical preparation for oral administration
EP0343703A2 (en) * 1988-05-26 1989-11-29 The Procter & Gamble Company Mineral supplements with sugar alcohols
JPH0567A (en) * 1991-06-20 1993-01-08 Towa Kasei Kogyo Kk Calcium-and dietary-fiber containing food and drink and production thereof
JPH0769902A (en) * 1993-02-25 1995-03-14 Meiji Seika Kaisha Ltd Magnesium replenishing material

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 8238, Derwent World Patents Index; AN 82-79053E, XP002028556 *
DATABASE WPI Week 8413, Derwent World Patents Index; AN 84-079196, XP002028557 *
DATABASE WPI Week 9306, Derwent World Patents Index; AN 93-049135, XP002028558 *
DATABASE WPI Week 9519, Derwent World Patents Index; AN 95-144716, XP002028559 *
KIRK-OTHMER ET AL.: "Encyclopedia of chemical technology", 1978, JOHN WILEY & SONS, NEW YORK, XP002028555 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319490B1 (en) * 1996-02-20 2001-11-20 Smithkline Beecham Plc Liquid oral compositions comprising a calcium compound and an acidulant
US6383473B1 (en) 1997-08-19 2002-05-07 Smithkline Beecham P.L.C. Solid composition for reducing tooth erosion
US6569477B2 (en) 1999-03-09 2003-05-27 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium and methods of making
WO2002052959A2 (en) * 2001-01-04 2002-07-11 The Procter & Gamble Company Beverage compositions comprising palatable calcium and magnesium sources
US6616955B2 (en) 2001-01-04 2003-09-09 The Proctor & Gamble Co. Beverage compositions comprising palatable calcium and magnesium sources
WO2002052959A3 (en) * 2001-01-04 2004-02-26 Procter & Gamble Beverage compositions comprising palatable calcium and magnesium sources
US20140161955A1 (en) * 2011-12-13 2014-06-12 Manpreet S. Wadhwa Liquid Dietary Supplement Formulation Compositions
US10251412B2 (en) * 2011-12-13 2019-04-09 Watermins Llc Liquid dietary supplement formulation compositions
US10638785B2 (en) 2011-12-13 2020-05-05 Watermins, LLC Liquid dietary supplement formulation compositions

Also Published As

Publication number Publication date
GB9525290D0 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
US4738856A (en) Beverage and method for making a beverage for the nutritional supplementation of calcium in humans
US7713559B2 (en) Amorphous water-soluble calcium citrate salts and method of making and using same
CA2146633C (en) Concentrated bioavailable calcium source
US4740380A (en) Calcium fortified acid beverages
EP1382263B1 (en) Use of calcium in acidic oral compositions for the reduction of tooth erosion caused by acid
CA1323793C (en) Calcium fortified food product
CA1306687C (en) Calcium-iron mineral supplements
EP0397232B1 (en) Vitamin and mineral supplements
EP0301653B1 (en) Calcium-supplemented beverages and beverage concentrates contaning low levels of sulfate
JPH06507640A (en) Mixed calcium and vitamin D supplements
JP2009062370A (en) Solid composition for reducing tooth erosion
AU8761591A (en) Tooth enamel erosion inhibitor
NZ239264A (en) Mineral supplement to counteract bone loss, comprising salts of ca, zn, mn, and cu
CA2367087A1 (en) Highly soluable and stable mineral supplements
WO1998032344A1 (en) CALCIUM FORTIFIED LOW pH BEVERAGE
US6461650B1 (en) Preparation for supplementing a beverage and method for enriching a beverage in calcium and magnesium
WO1997021356A1 (en) Mineral enriched beverages
JPH0223154B2 (en)
JPH02119761A (en) Calcium lactate-containing drink and solid preparation
JPH07203922A (en) Calcium-supplied and enriched drink and solid drink

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN GB JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97521839

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase